<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Burns Trauma</journal-id><journal-id journal-id-type="iso-abbrev">Burns Trauma</journal-id><journal-title-group><journal-title>Burns &#x00026; Trauma</journal-title></journal-title-group><issn pub-type="ppub">2321-3868</issn><issn pub-type="epub">2321-3876</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27574616</article-id><article-id pub-id-type="pmc">4994495</article-id><article-id pub-id-type="publisher-id">10010005</article-id><article-id pub-id-type="doi">10.4103/2321-3868.113329</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Biofilm delays wound healing: A review of the evidence</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Metcalf</surname><given-names>Daniel G.</given-names></name><address><email>daniel.metcalf@convatec.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Bowler</surname><given-names>Philip G.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label>Infection Prevention, ConvaTec Ltd., Global Development Centre, First Avenue, Deeside Industrial Park, Flintshire, CH5 2NU UK </aff><aff id="Aff2"><label>2</label>ConvaTec Global Development Centre, First Avenue, Deeside Industrial Park, Flintshire, CH5 2NU UK </aff></contrib-group><pub-date pub-type="epub"><day>26</day><month>6</month><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>26</day><month>6</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2013</year></pub-date><volume>1</volume><issue>1</issue><fpage>5</fpage><lpage>12</lpage><permissions><copyright-statement>&#x000a9; Author 2013</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made</license-p></license></permissions><abstract id="Abs1"><p>Biofilm is the predominant mode of life for bacteria and today it is implicated in numerous human diseases. A growing body of scientific and clinical evidence now exists regarding the presence of biofilm in wounds. This review summarizes the clinical experiences and <italic>in vivo</italic> evidence that implicate biofilm in delayed wound healing. The various mechanisms by which biofilm may impede healing are highlighted, including impaired epithelialization and granulation tissue formation, and reduced susceptibilities to antimicrobial agents and host defenses. Strategies to manage biofilm and encourage progression to wound healing are discussed; these include debridement and appropriate antimicrobial therapies which may be improved upon in the future with the emergence of anti-biofilm technologies.</p></abstract><kwd-group xml:lang="en"><title>Key words</title><kwd>Biofilm</kwd><kwd>delayed healing</kwd><kwd>evidence</kwd><kwd>wound</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2013</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Biofilm natural history and medical significance</title><p>Bacteria are ubiquitous in nature, and while the majority are harmless and important in life and for human health, some are capable of causing disease. Whether they develop within natural or pathogenic ecosystems, bacteria have a preference for existence as a surface-attached community, rather than as a planktonic (free-floating) mode of life. It has been suggested that bacteria evolved as surface-attached organisms, and that a planktonic phenotype subsequently evolved as a dispersal and seeding mechanism.[<xref ref-type="bibr" rid="CR1">1</xref>]</p><p>The observation of bacterial aggregation and attachment to the surface of teeth was first made by van Leewenhoek in the late 1600s, but it was not until the 1970s, when researchers had access to more advanced microscopy and traditional microbiology techniques, that the true significance of surface-attached bacteria in ecosystems as diverse as the bovine stomach and alpine streams was realized. Investigation of granite rocks in a Canadian alpine stream revealed that the bacterial population embedded within a slippery slime layer on rock surfaces outnumbered planktonic bacteria in the steam water by a factor of 1,000-10,000;[<xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR3">3</xref>] this emphasizes the preference of bacteria to attach to surfaces. It was during this period that the term &#x02018;biofilm&#x02019; was first used to describe surface-adherent bacteria encased within, and protected by a self-produced glycocalyx (today more commonly referred to as extracellular polymeric substance, or EPS).[<xref ref-type="bibr" rid="CR3">3</xref>] Biofilm research since the 1970s has been extensive, with substantial evidence indicating that bacteria exist predominantly as a biofilm phenotype in medical, natural and industrial ecosystems.[<xref ref-type="bibr" rid="CR3">3</xref>] The impact of biofilm in waste water filtration, biofouling of industrial materials, metal corrosion, and human chronic bacterial infections has been widely documented.<table-wrap id="Taba"><table frame="hsides" rules="groups"><thead><tr><th colspan="2">Access this article online</th></tr></thead><tbody><tr><td rowspan="2"><bold>Quick Response Code</bold>: <inline-graphic xlink:href="41038_2015_10010005_Figa.gif" id="d30e224"/></td><td><bold>Website</bold>: <ext-link ext-link-type="uri" xlink:href="http://www.burnstrauma.com">www.burnstrauma.com</ext-link></td></tr><tr><td><bold>DOI</bold>: 10.4103/2321-3868.113329</td></tr></tbody></table></table-wrap></p><p>Today, biofilm is implicated in numerous bacterial infections including those associated with the urinary tract, ear, sinuses, indwelling catheters, cystic fibrosis, periodontal disease and chronic wounds. Research undertaken during the 1970s, predominantly pioneered by J. William Costerton (the father of biofilmology), showed that &#x02018;healthy&#x02019; biofilm on normal tissue surfaces provided protection against pathogenic colonization,[<xref ref-type="bibr" rid="CR4">4</xref>] and that pathogenic biofilm predominated in infected tissues associated with chronic endocarditis and indwelling devices.[<xref ref-type="bibr" rid="CR5">5</xref>] Additionally, it became evident that infections associated with bacterial biofilm persisted despite aggressive antimicrobial chemotherapy[<xref ref-type="bibr" rid="CR6">6</xref>] Biofilm tolerance to antimicrobial agents[<xref ref-type="bibr" rid="CR7">7</xref>] and host defense mechanisms[<xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR9">9</xref>] is now well documented, and this highlights the importance of effective biofilm management in chronic infections.</p><p>There is no doubt that biofilm exists in some wounds, and in the last decade a growing body of supportive evidence has emerged.[<xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR13">13</xref>] <xref rid="Tab1" ref-type="table">Table 1</xref> summarizes some key scientific evidence for the presence of biofilm in wounds.[<xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR14">14</xref>&#x02013;<xref ref-type="bibr" rid="CR19">19</xref>] It is likely that at least half of all chronic wounds contain biofilm,[<xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR11">11</xref>] the implications of which are considerable. If a majority of non-healing wounds contain biofilm, and it has a role in delayed healing, then biofilm could be contributing many billions of dollars to the global cost of chronic wounds.[<xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR21">21</xref>] Recent evidence from animal models has demonstrated that biofilm creates a low-grade and persistent inflammatory response, and impairs both epithelialization and granulation tissue formation.[<xref ref-type="bibr" rid="CR22">22</xref>] Additionally, due to clinical observations of suspected biofilm, specific biofilm-based wound management is now being practised.[<xref ref-type="bibr" rid="CR12">12</xref>] This review will focus on the most recent clinical experiences and <italic>in vivo</italic> evidence from relevant animal models to summarize the latest knowledge of the effects of biofilm on wound healing.</p><table-wrap id="Tab1"><label>Table 1:</label><caption><p>Key scientific evidence for the presence of biofilm in human wounds</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Wound type</th><th align="left">No.</th><th align="left">Methods</th><th align="left">Observations</th><th align="left">Reference</th></tr></thead><tbody><tr><td align="left">Chronic wounds</td><td align="left">50</td><td align="left">Light microscopy, scanning electron microscopy (SEM)</td><td align="left">30 (60%) chronic wounds observed to contain biofilm</td><td align="left">James <italic>et al.</italic> (2008)[<xref ref-type="bibr" rid="CR10">10</xref>]</td></tr><tr><td align="left">Acute wounds</td><td align="left">16</td><td align="left">Light microscopy, SEM</td><td align="left">1 (6%) acute wound contained biofilm</td><td align="left">James <italic>et al.</italic> (2008)[<xref ref-type="bibr" rid="CR10">10</xref>]</td></tr><tr><td align="left">Chronic wounds</td><td align="left">22</td><td align="left">Confocal microscopy</td><td align="left">13 (59%) chronic wounds contained biofilm</td><td align="left">Kirketerp-M&#x000f8;ller <italic>et al.</italic> (2008)[<xref ref-type="bibr" rid="CR11">11</xref></td></tr><tr><td align="left">Chronic wounds</td><td align="left">2</td><td align="left">Fluorescence microscopy</td><td align="left">Both samples contained biofilm</td><td align="left">Bjarnsholt <italic>et al.</italic> (2008)[<xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td align="left">Chronic wounds</td><td align="left">10</td><td align="left">Fluorescence microscopy, confocal microscopy</td><td align="left"><italic>Pseudomonas aeruginosa</italic> biofilm seen deeper in wound bed than <italic>Staphylococcus aureus</italic></td><td align="left">Fazli <italic>et al.</italic> (2009)[<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">Chronic wounds</td><td align="left">10</td><td align="left">Fluorescence microscopy, confocal microscopy</td><td align="left"><italic>P. aeruginosa</italic> biofilm elicited greater inflammation than <italic>S. aureus</italic></td><td align="left">Fazli <italic>et al.</italic> (2011)[<xref ref-type="bibr" rid="CR16">16</xref>]</td></tr><tr><td align="left">Mixed etiologies</td><td align="left">15</td><td align="left">Fluorescence microscopy</td><td align="left">7 (47%) wounds contained biofilm</td><td align="left">Han <italic>et al.</italic> (2011)[<xref ref-type="bibr" rid="CR17">17</xref>]</td></tr><tr><td align="left">Diabetic foot ulcers</td><td align="left">2</td><td align="left">Confocal microscopy</td><td align="left">Both samples contained biofilm</td><td align="left">Neut <italic>et al.</italic> (2011)[<xref ref-type="bibr" rid="CR18">18</xref>]</td></tr><tr><td align="left">Full-thickness burns</td><td align="left">11</td><td align="left">Light microscopy, transmission electron microscopy, SEM</td><td align="left">Ulcerated areas and escharotomy sites contained biofilm; non-ulcerated areas did not</td><td align="left">Kennedy <italic>et al.</italic> (2010)[<xref ref-type="bibr" rid="CR19">19</xref>]</td></tr></tbody></table></table-wrap></sec><sec id="Sec2"><title>Biofilm and wound healing</title><sec id="Sec3"><title>Clinical evidence</title><p>In a series of case studies, Hurlow (2009 and 2012) described management of wound biofilm using carefully selected combinations of debridement, antimicrobials and dressing technologies [<xref rid="Tab2" ref-type="table">Table 2</xref>].[<xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR23">23</xref>] <xref rid="Fig1" ref-type="fig">Figure 1</xref> shows an example of an infected traumatic wound undergoing curettage to debride biofilm that appeared to be impeding granulation tissue formation. Careful management of infection, exudate and underlying pathophysiologies were complemented by this approach.[<xref ref-type="bibr" rid="CR23">23</xref>] Hurlow&#x02019;s work also highlighted key differences between the origins, composition and behavior of slough and biofilm. Slough is dead or devitalized proteinaceous host tissue, but contiguous with underlying viable tissue.[<xref ref-type="bibr" rid="CR13">13</xref>] On the other hand, biofilm is viable, bacteria-derived tissue, comprised of bacteria in a matrix of EPS which is thought to be primarily polysaccharide-based.[<xref ref-type="bibr" rid="CR28">28</xref>] This distinction is exemplified in <xref rid="Fig2" ref-type="fig">Figure 2</xref> which shows a dehisced surgical wound with suggestive biofilm in addition to peripheral slough. The claim that biofilm is sometimes visible in wounds with the naked eye[<xref ref-type="bibr" rid="CR23">23</xref>] has initiated lively debate amongst the global wound care community.[<xref ref-type="bibr" rid="CR29">29</xref>] A shiny, translucent, slimy layer in the wound bed had already been used as a clinical sign of biofilm, especially if it returned quickly after sharp debridement.[<xref ref-type="bibr" rid="CR30">30</xref>] It has recently been argued that there is no conclusive <italic>in vivo</italic> proof that biofilm exists in wounds <italic>perse</italic><sup>+</sup>; however, the authors highlight the need for biofilm detection technology and support biofilm-based wound care (BBWC).[<xref ref-type="bibr" rid="CR31">31</xref>]</p><table-wrap id="Tab2"><label>Table 2:</label><caption><p>Clinical evidence that biofilm delays wound healing</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Wound type</th><th align="left">No.</th><th align="left">Clinical observations</th><th align="left">Biofilm management</th><th align="left">Reference</th></tr></thead><tbody><tr><td align="left">Non-healing surgical ulcer</td><td align="left">1</td><td align="left">Cloudy, shiny, thin film of slime, after lavage, enzymatic ointment and a silver alginate dressing</td><td align="left">Curettage gently scraped away film; managed underlying pathophysiology</td><td align="left">Hurlow &#x00026; Bowler (2009)[<xref ref-type="bibr" rid="CR13">13</xref>]</td></tr><tr><td align="left">Venous leg ulcer (VLU)</td><td align="left">1</td><td align="left">Thick, visible film, after lavage, collagenase debridement and a silver alginate dressing</td><td align="left">Continual debridement plus negative pressure wound therapy and split-thickness graft</td><td align="left">Hurlow &#x00026; Bowler (2009)[<xref ref-type="bibr" rid="CR13">13</xref>]</td></tr><tr><td align="left">VLU</td><td align="left">1</td><td align="left">Persistent, cloudy, translucent film, after a silver alginate dressing</td><td align="left">Sodium hypochlorite wound cleanser between dressing changes</td><td align="left">Hurlow &#x00026; Bowler (2009)[<xref ref-type="bibr" rid="CR13">13</xref>]</td></tr><tr><td align="left">Diabetic with cellulitis</td><td align="left">2</td><td align="left">Visible, opaque, pale yellow films</td><td align="left">Antibiotics, debridement and a silver carboxymethyl cellulose dressing</td><td align="left">Hurlow &#x00026; Bowler (2012)[<xref ref-type="bibr" rid="CR23">23</xref>]</td></tr><tr><td align="left">Highly exuding</td><td align="left">3</td><td align="left">Thick, green-tinted or translucent film, after inappropriate dressings (polyurethane, hydrogel or foam dressings)</td><td align="left">Two wounds healed using antibiotics, debridement and a silver carboxymethyl cellulose dressing</td><td align="left">Hurlow &#x00026; Bowler (2012)[<xref ref-type="bibr" rid="CR23">23</xref>]</td></tr><tr><td align="left">Peripheral arterial disease (PAD)</td><td align="left">3</td><td align="left">Cloudy and translucent film / opaque film / red/green film</td><td align="left">Sharp debridement and a silver carboxylmethyl cellulose dressing</td><td align="left">Hurlow &#x00026; Bowler (2012)[<xref ref-type="bibr" rid="CR23">23</xref>]</td></tr><tr><td align="left">Critically ischemic lower limb wounds</td><td align="left">190</td><td align="left">77% (146) wounds healed</td><td align="left">Combinations of sharp and ultrasonic debridement, lactoferrin/xylitol, cadexomer iodine and silver dressings</td><td align="left">Wolcott &#x00026; Rhoads (2008)[<xref ref-type="bibr" rid="CR12">12</xref>]</td></tr><tr><td align="left">Dehisced</td><td align="left">4</td><td align="left">Healing</td><td align="left">Sharp debridement</td><td align="left">Wolcott <italic>et al.</italic> (2010)[<xref ref-type="bibr" rid="CR24">24</xref>]</td></tr><tr><td align="left">Lower limb traumatic in a PAD patient</td><td align="left">1</td><td align="left">Wound had become chronic with suspected biofilm</td><td align="left">Healed over 6 months using BBWC</td><td align="left">Wolcott <italic>et al.</italic> (2010)[<xref ref-type="bibr" rid="CR25">25</xref>]</td></tr><tr><td align="left">Traumatic chemical burn in a diabetic</td><td align="left">1</td><td align="left">Infection developed and patient was declared an amputation case</td><td align="left">Healed in 12 weeks using debridement, systemic and topical antibiotics and silver dressings</td><td align="left">Wolcott &#x00026; Dowd (2011)[<xref ref-type="bibr" rid="CR26">26</xref>]</td></tr><tr><td align="left">Mixed etiologies undergoing cell-based therapy</td><td align="left">97</td><td align="left">Entire graft material remained intact with biofilm suppression</td><td align="left">Debridement and personalised topical gels containing anti-biofilm agents and antibiotics</td><td align="left">Wolcott &#x00026; Cox (2013)[<xref ref-type="bibr" rid="CR27">27</xref>]</td></tr></tbody></table></table-wrap><fig id="Fig1"><label>Figure 1:</label><caption><p>An infected traumatic leg ulcer in a diabetic patient with moderate peripheral arterial disease. Curettage was used to remove the pale yellow, slimy biofilm from the wound. Small buds of granulation tissue can be seen beneath the biofilm.</p></caption><graphic xlink:href="41038_2015_10010005_Fig1" id="MO1"/></fig><fig id="Fig2"><label>Figure 2:</label><caption><p>A dehisced surgical incision in a relatively ischemic patient. The opaque film on the wound bed (centre) re-formed daily and could be lifted off to reveal intact granular buds. Ultrasonic debridement was ineffective at disrupting or removing this thick, mature biofilm. Slough is also evident on the intact skin around the wound (top centre, top right, bottom right).</p></caption><graphic xlink:href="41038_2015_10010005_Fig2" id="MO2"/></fig><p>In recent years, Wolcott and colleagues have embarked on a series of clinical investigations which have advanced our understanding of the characterization, behavior and impact of biofilm in chronic and acute wounds [<xref rid="Tab2" ref-type="table">Table 2</xref>].[<xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR24">24</xref>&#x02013;<xref ref-type="bibr" rid="CR27">27</xref>]</p><p>BBWC is an algorithm, including debridement, antimicrobial dressings, anti-biofilm agents and antibiotics, used to most efficiently suppress wound biofilm and encourage healing. In a retrospective clinical study, the improved level of healing achieved using BBWC was found to be statistically significant.[<xref ref-type="bibr" rid="CR12">12</xref>] The value of regular debridement was demonstrated in a series of scientific, animal and clinical analyses, which showed that debridement opens up a therapeutic window where bacteria are more susceptible to antimicrobial agents,[<xref ref-type="bibr" rid="CR32">32</xref>] so is key to maintaining a healthy wound bed.[<xref ref-type="bibr" rid="CR33">33</xref>] A recent retrospective study examined a group of 97 patients with various wounds that received BBWC in conjunction with cell-based therapy. Compared to previous studies which did not use BBWC, these bespoke protocols of care were shown to result in a statistically significant improvement in wound healing following cell-based therapy[<xref ref-type="bibr" rid="CR27">27</xref>] <xref rid="Fig3" ref-type="fig">Figure 3</xref> shows an example of how debridement in conjunction with a silver carboxymethyl cellulose dressing was used to successfully transform a biofilm-colonized dehisced incision [<xref rid="Fig3" ref-type="fig">Figure 3a</xref>] to a healing wound [<xref rid="Fig3" ref-type="fig">Figure 3b</xref>].</p><fig id="Fig3"><label>Figure 3:</label><caption><p>A dehisced mastectomy incision wound in a patient who had undergone chemotherapy. (a) Debridement in conjunction with a silver carboxymethyl cellulose dressing was used to transform a biofilm colonized wound. (b) Debridement in conjunction with a silver carboxymethyl cellulose dressing was used to transform a healing wound.</p></caption><graphic xlink:href="41038_2015_10010005_Fig3" id="MO3"/></fig><p>These clinical experiences, case studies and retrospective studies are of great value as we begin to understand the effect of biofilm on wound healing. However, in the absence of a non-invasive, point-of-care biofilm detection method, it is challenging to use human patients to conduct randomized or prospective trials on the subject. It is also unethical to consider deliberate establishment of biofilm in human patients. Therefore, the use of animal models is justifiable in investigating this significant human health problem. Moreover, certain animal wound models are relevant to human wound healing in terms of host response such as the production of macrophages, neutrophils, inflammatory enzymes and keratinocytes. Porcine, murine and rabbit ear wound models are all recognized for their value in better understanding human wound pathophysiology and healing.</p></sec><sec id="Sec4"><title>Animal evidence</title><p>Studies using the porcine acute wound model suggested that biofilm physically impairs the immune responses associated with healing [<xref rid="Tab3" ref-type="table">Table 3</xref>].[<xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR35">35</xref>] The authors described how continuous antimicrobial treatment was needed to control biofilm-colonized wounds, and that debridement was a critical step to reduce bioburden before therapeutics are applied,[<xref ref-type="bibr" rid="CR49">49</xref>] as has been described clinically[<xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR33">33</xref>] A porcine model has demonstrated that encouraging the establishment and resilience of wound biofilm exacerbates delayed healing [<xref rid="Tab3" ref-type="table">Table 3</xref>].[<xref ref-type="bibr" rid="CR36">36</xref>] Most recently, the interaction between <italic>S. aureus</italic> and <italic>P. aeruginosa</italic> in biofilms has been demonstrated in the porcine model where healing was significantly delayed [<xref rid="Tab3" ref-type="table">Table 3</xref>].[<xref ref-type="bibr" rid="CR37">37</xref>] Murine models have been used to demonstrate the importance of <italic>P. aeruginosa biofilm</italic>-forming virulence factors,[<xref ref-type="bibr" rid="CR38">38</xref>] and that EPS protects bacteria from antibiotics and host defenses [<xref rid="Tab3" ref-type="table">Table 3</xref>].[<xref ref-type="bibr" rid="CR39">39</xref>] The diabetic mouse chronic wound model has shown that <italic>P. aeruginosa</italic> biofilm significantly delayed healing by two to four weeks without impairing the general health of the subject [<xref rid="Tab3" ref-type="table">Table 3</xref>].[<xref ref-type="bibr" rid="CR40">40</xref>,<xref ref-type="bibr" rid="CR41">41</xref>] Treating diabetic mice with insulin did not prevent delayed healing, actually promoting <italic>P. aeruginosa</italic> biofilm [<xref rid="Tab3" ref-type="table">Table 3</xref>],[<xref ref-type="bibr" rid="CR42">42</xref>] which has also been shown to be resistant to undiluted sodium hypochlorite.[<xref ref-type="bibr" rid="CR32">32</xref>] Polymicrobial biofilm comprised of four species delayed murine wound closure significantly more than single-species biofilm over 12 days [<xref rid="Tab3" ref-type="table">Table 3</xref>].[<xref ref-type="bibr" rid="CR43">43</xref>]</p><table-wrap id="Tab3"><label>Table 3:</label><caption><p>Animal evidence that biofilm delays wound healing from porcine, murine and rabbit ear wound models</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Model</th><th align="left">Biofilm species</th><th align="left">Observations</th><th align="left">Reference</th></tr></thead><tbody><tr><td align="left">Porcine acute wound</td><td align="left">
<italic>S. aureus</italic>
</td><td align="left">Challenge with antimicrobial agents confirmed the recalcitrance of biofilm bacteria</td><td align="left">Serralta <italic>et al.</italic> (2001)[<xref ref-type="bibr" rid="CR34">34</xref>]</td></tr><tr><td align="left">Porcine acute wound</td><td align="left">
<italic>S. aureus</italic>
</td><td align="left">Indirect evidence of delayed healing, with polymorphonucleocytes observed on the surface of, but not within, biofilm</td><td align="left">Davis <italic>et al.</italic> (2008)[<xref ref-type="bibr" rid="CR35">35</xref>]</td></tr><tr><td align="left">Porcine acute wound</td><td align="left">Methicillin-resistant <italic>S. aureus</italic> (MRSA)</td><td align="left">Greater healing delays were observed due to biofilm formed by passaged MRSA strains than by parent strains; passaged strain was observed to form more biofilm than parent strain</td><td align="left">Roche <italic>et al.</italic> (2012)[<xref ref-type="bibr" rid="CR36">36</xref>]</td></tr><tr><td align="left">Porcine partial-thickness wound</td><td align="left">MRSA, <italic>P . aeruginosa</italic></td><td align="left">Interactions between MRSA and <italic>P. aeruginosa</italic> were observed, delaying healing due to suppression of epithelialization and expression of virulence factors</td><td align="left">Pastar <italic>et al.</italic> (2013)[<xref ref-type="bibr" rid="CR37">37</xref>]</td></tr><tr><td align="left">Murine burn</td><td align="left">
<italic>P. aeruginosa</italic>
</td><td align="left">A biofilm-forming factor established <italic>in vitro</italic> was a key virulence factor <italic>in vivo</italic></td><td align="left">Rashid <italic>et al.</italic> (2000)[<xref ref-type="bibr" rid="CR38">38</xref>]</td></tr><tr><td align="left">Murine burn</td><td align="left">
<italic>P. aeruginosa</italic>
</td><td align="left">Microscopic biofilm that was not readily removed by rinsing with saline</td><td align="left">Schaber <italic>et al.</italic> (2007)[<xref ref-type="bibr" rid="CR39">39</xref>]</td></tr><tr><td align="left">Murine diabetic chronic wound</td><td align="left">
<italic>P. aeruginosa</italic>
</td><td align="left">(<italic>In vitro</italic> then inoculated) biofilm significantly delayed healing compared to controls; health parameters in biofilm-colonized mice were normal</td><td align="left">Zhao <italic>et al.</italic> (2010)[<xref ref-type="bibr" rid="CR40">40</xref>]</td></tr><tr><td align="left">Murine diabetic chronic wound</td><td align="left">
<italic>P. aeruginosa</italic>
</td><td align="left">(<italic>In vitro</italic> then inoculated) biofilm-colonized wounds had high levels of inflammatory cells; 8 weeks for all biofilm-colonized wounds to heal, compared to 4 weeks for controls</td><td align="left">Zhao <italic>et al.</italic> (2012)[<xref ref-type="bibr" rid="CR41">41</xref>]</td></tr><tr><td align="left">Murine diabetic chronic wound</td><td align="left">
<italic>P. aeruginosa</italic>
</td><td align="left">Biofilm significantly delayed wound healing, even in diabetic mice treated with insulin</td><td align="left">Watters <italic>et al.</italic> (2012)[<xref ref-type="bibr" rid="CR42">42</xref>]</td></tr><tr><td align="left">Murine chronically infected surgical wound</td><td align="left">
<italic>P. aeruginosa</italic>
</td><td align="left">Biofilm was highly resistant to antibiotics and undiluted sodium hypochlorite once established over several days</td><td align="left">Wolcott <italic>et al.</italic> (2010)[<xref ref-type="bibr" rid="CR32">32</xref>]</td></tr><tr><td align="left">Murine chronically infected surgical wound</td><td align="left"><italic>S. aureus</italic>, <italic>P. aeruginosa</italic>, <italic>Enterococcus faecalis</italic>, <italic>Finegoldia magna</italic></td><td align="left">(<italic>In vitro</italic> then inoculated) polymicrobial biofilm was maintained for 12 days, and delayed healing more than <italic>P. aeruginosa</italic> biofilm, as measured by wound closure</td><td align="left">Dalton <italic>et al.</italic> (2011)[<xref ref-type="bibr" rid="CR43">43</xref>]</td></tr><tr><td align="left">Murine splinted wound</td><td align="left"><italic>S. aureus</italic> or <italic>Staphylococcus epidermidis</italic></td><td align="left">Biofilms significantly delayed epithelialization; inhibition of biofilm restored normal wound healing</td><td align="left">Schierle <italic>et al.</italic> (2009)[<xref ref-type="bibr" rid="CR44">44</xref>]</td></tr><tr><td align="left">Rabbit ear wound</td><td align="left">
<italic>S. aureus</italic>
</td><td align="left">Biofilm and active infection significantly delayed epithelialization and granulation tissue formation; biofilm-colonized wounds expressed significantly lower levels of inflammatory cytokines than infected wounds</td><td align="left">Gurjala <italic>et al.</italic> (2011)[<xref ref-type="bibr" rid="CR22">22</xref>]</td></tr><tr><td align="left">Rabbit ear wound</td><td align="left">
<italic>P. aeruginosa</italic>
</td><td align="left">Biofilm significantly delayed epithelialization and granulation tissue formation; debridement, lavage and silver sulphadiazine in combination were more effective at restoring healing than individua treatments</td><td align="left">Seth <italic>et al.</italic> (2012a)[<xref ref-type="bibr" rid="CR45">45</xref>]</td></tr><tr><td align="left">Rabbit ischemic ear wound</td><td align="left">
<italic>Klebsiella pneumoniae</italic>
</td><td align="left">Biofilm formed readily in ischemic wounds but not in non-ischemic wounds where neutrophils and macrophages were seen</td><td align="left">Seth <italic>et al.</italic> (2012b)[<xref ref-type="bibr" rid="CR46">46</xref>]</td></tr><tr><td align="left">Rabbit ischemic ear wound</td><td align="left"><italic>K. pneumoniae</italic>, <italic>S. aureus</italic>, <italic>P. aeruginosa</italic></td><td align="left"><italic>K. pneumoniae</italic> biofilm was least virulent, <italic>P. aeruginosa</italic> biofilm most virulent, measured by healing inhibition and inflammatory responses; EPS-deficient <italic>P. aeruginosa</italic> did not delay healing</td><td align="left">Seth <italic>et al.</italic> (2012c)[<xref ref-type="bibr" rid="CR47">47</xref>]</td></tr><tr><td align="left">Rabbit ear wound</td><td align="left"><italic>S. aureus</italic>, <italic>P. aeruginosa</italic></td><td align="left">Two-species biofilm elicited significantly elevated inflammatory response and impaired epithelialization and granulation tissue formation compared to single-species biofilm</td><td align="left">Seth <italic>et al.</italic> (2012d)[<xref ref-type="bibr" rid="CR48">48</xref>]</td></tr></tbody></table></table-wrap><p>The Northwestern University group in Chicago has conducted a series of <italic>in vivo</italic> studies in recent years, expanding our understanding of the effect of biofilm on wound healing [<xref rid="Tab3" ref-type="table">Table 3</xref>]. Visible biofilm was observed to significantly delay closure of the epithelial gap in a murine splinted wound model [<xref rid="Tab3" ref-type="table">Table 3</xref>],[<xref ref-type="bibr" rid="CR44">44</xref>] before an established, reproducible and Food &#x00026; Drug Administration (FDA)-recognized rabbit dermal ulcer model of wound healing was adopted.[<xref ref-type="bibr" rid="CR50">50</xref>] This model utilizes full-thickness punch wounds through to the cartilage of rabbit ears, closely representing the dermal damage observed in human chronic wounds. Biofilms of <italic>S. aureus</italic>[<xref ref-type="bibr" rid="CR22">22</xref>] and <italic>P. aeruginosa</italic>[<xref ref-type="bibr" rid="CR45">45</xref>] significantly delayed healing in terms of epithelialization and granulation tissue formation, with biofilm-colonized wounds expressing significantly lower levels of inflammatory markers than clinically infected wounds [<xref rid="Tab3" ref-type="table">Table 3</xref>]. Combinations of treatments in an anti-biofilm protocol of care were also shown to be more effective at encouraging wound healing than individual treatments [<xref rid="Tab3" ref-type="table">Table 3</xref>].[<xref ref-type="bibr" rid="CR45">45</xref>] Biofilms of the opportunistic pathogen, <italic>Klebsiella pneumoniae</italic>, associated with burn and war wounds, were shown to impair healing of ischemic rabbit ear wounds,[<xref ref-type="bibr" rid="CR46">46</xref>] but to a lesser extent than <italic>P. aeruginosa</italic> or <italic>S. aureus</italic> [<xref rid="Tab3" ref-type="table">Table 3</xref>].[<xref ref-type="bibr" rid="CR47">47</xref>] A further study demonstrated synergy between different species in biofilm, further delaying wound healing compared to single-species biofilm [<xref rid="Tab3" ref-type="table">Table 3</xref>],[<xref ref-type="bibr" rid="CR48">48</xref>] as has been demonstrated in murine models.[<xref ref-type="bibr" rid="CR43">43</xref>]</p><p>Despite the limitations of the rabbit ear wound healing model (e.g. an acute wound modeling a human chronic wound), its advantages over other animal models are clear and have recently been the subject of a review[<xref ref-type="bibr" rid="CR51">51</xref>] As a highly controlled <italic>in vivo</italic> wound biofilm model, the rabbit ear model is also useful for assessing new anti-biofilm or antimicrobial technologies.[<xref ref-type="bibr" rid="CR52">52</xref>,<xref ref-type="bibr" rid="CR53">53</xref>]</p></sec></sec><sec id="Sec5"><title>Management of wound biofilm</title><p>Based on the clinical and <italic>in vivo</italic> experiences summarized above, it is possible to devise effective anti-biofilm strategies, similar to BBWC, to encourage wound healing in everyday clinical practice. Indeed, the Tissue-Inflammation/Infection-Moisture-Edge (TIME) concept has recently been updated to include biofilm management as a key consideration in wound bed preparation.[<xref ref-type="bibr" rid="CR54">54</xref>]</p><sec id="Sec6"><title>Debridement</title><p>Physical debridement of foreign material is clearly the simplest, and currently the most effective method to remove these impediments to healing. Whilst clinicians have long appreciated that debridement of slough can encourage healing, the evidence suggests that this process also removes bacteria, in the form of contaminated or colonized slough, as well as biofilm. Debridement techniques range from specialist surgical and sharp debridement, gentler mechanical debridement with curettes, fabric pads, lavage or ultrasound, to autolytic debridement with moisture-retentive dressings.[<xref ref-type="bibr" rid="CR55">55</xref>] There may also be a place for chemical debridement using rinse solutions or gels containing antiseptics such as sodium hypochlorite or hypochlorous acid.[<xref ref-type="bibr" rid="CR56">56</xref>,<xref ref-type="bibr" rid="CR57">57</xref>] Whichever method is utilized, the main clinical and <italic>in vivo</italic> observations are that biofilm re-forms rapidly-certainly daily, and likely within hours,[<xref ref-type="bibr" rid="CR58">58</xref>] so regular debridement is key.[<xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR33">33</xref>] In addition, whereas slough may be contiguous with healthier underlying host tissue, biofilm may be more surface-associated so may respond well to gentler methods of debridement such as curettage, fabric pads or skin-safe chemical rinses. Moreover, although the aim of debridement is to remove devitalized tissue and &#x02018;beat back&#x02019; biofilm to stop it re-forming,[<xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR33">33</xref>] it will only be effective if followed up with appropriate antimicrobials and wound management products.</p></sec><sec id="Sec7"><title>Topical antimicrobials</title><p>The abundance of currently-available antimicrobial agents (e.g. antibiotics, cleansers, gels, dressings) may be confusing to healthcare professionals. Antibiotics should be used responsibly and only when clinical infection is suspected or confirmed by clinical and microbiological assessment. Effective debridement of biofilm removes some of the protection bacteria are offered by EPS, forcing the remaining bacteria to revert to a more metabolically active form, so antibiotics (which are designed to kill planktonic bacteria), and topical antiseptics such as silver, iodine and polyhexamethylene biguanide (PHMB), are made more effective.[<xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR33">33</xref>] Perhaps as important as the antiseptic selected is the delivery vehicle used, which must interact optimally with the wound microenvironment. For example, in an exuding wound with suspected biofilm, a highly-absorbent antiseptic dressing should be used after effective debridement-the use of antiseptic gauze or mesh would be inappropriate, due to their poor exudate management capabilities. Prudent combinations of debridement, antimicrobials and wound management products is currently the best available protocol of care for wounds with suspected biofilm or infection.[<xref ref-type="bibr" rid="CR12">12</xref>] However, the anti-biofilm efficacy of most currently available topical antimicrobial products is limited.</p></sec><sec id="Sec8"><title>Anti-biofilm agents</title><p>As we begin to appreciate the source (bacterial), composition (EPS or &#x02018;slime&#x02019;) and behavior (re-forms quickly) of wound biofilm, opportunities to improve on current wound care are presented. For example, in the future it may be possible to formulate wound care products, such as debridement pads, rinses or dressings, with agents that penetrate through biofilm EPS, thus exposing the bacteria and increasing their susceptibility to antimicrobials. Detergent-type agents could help to remove biofilm from the wound bed, or chemicals could be used that weaken the matrix to collapse biofilms which could then be mopped up by absorbent dressings. A number of such potential anti-biofilm agents have been proposed, such as xylitol, lactoferrin and ethylenediaminetetraacetic acid (EDTA),[<xref ref-type="bibr" rid="CR12">12</xref>] but convincing clinical or <italic>in vivo</italic> evidence for their efficacy is lacking. A key challenge to science and industry is to better understand the composition of wound biofilm in terms of polysaccharide, protein, extracellular DNA and ions, in order to formulate anti-biofilm technologies. At least daily, we all use combinations of debridement, detergents and antimicrobials to manage oral plaque biofilm and maintain oral hygeine,[<xref ref-type="bibr" rid="CR59">59</xref>] and this multi-modal approach is most likely how wound biofilm can be effectively managed to encourage wound healing.</p></sec><sec id="Sec9"><title>Biofilm detection</title><p>The current accepted gold standard for biofilm detection in wounds is by microscopic examination using expensive and specialized techniques such as confocal microscopy or electronic microscopy. Although in some instances, biofilm may be visible to the trained clinical eye,[<xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR30">30</xref>] the need for wound biofilm detection techniques for use at the point-of-care is clear.[<xref ref-type="bibr" rid="CR31">31</xref>,<xref ref-type="bibr" rid="CR54">54</xref>,<xref ref-type="bibr" rid="CR60">60</xref>] Biofilm detection would enable more effective wound bed preparation techniques if the clinician could visualize if and where biofilm is present in the wound, perhaps by staining or tagging biofilm components to render them visible.[<xref ref-type="bibr" rid="CR60">60</xref>] This would also enable the most appropriate and effective selection of antimicrobials and dressings, with associated cost savings, which are becoming increasingly important in global healthcare.</p></sec></sec><sec id="Sec10" sec-type="conclusion"><title>Conclusion</title><p>By taking into account the growing body of scientific and clinical evidence regarding wound biofilm, this review has highlighted a multitude of mechanisms by which biofilm may be implicated in delayed healing. Biofilm is associated with impaired epithelialization and granulation tissue formation, and promotes a low-grade inflammatory response that interferes with wound healing. Polymicrobial biofilms, which invariably exist in chronic wounds, have been shown to delay healing to a greater extent than single-species biofilms. Taking these effects into account, wound biofilm likely evolves as a cryptic ecosystem that at some point is sufficiently established to interfere with wound healing, and if not managed effectively may progress to infection.</p><p>From a therapeutic perspective, multi-modal approaches to wound management, particularly involving frequent physical debridement and antimicrobial therapy have been shown to enhance healing to a greater extent than single therapies in both animal and human studies. Whilst frequent physical removal of wound biofilm and appropriate antibiotic and topical antimicrobial therapies are perhaps best practice today, there is clearly a need for new medical devices (including dressings) that are able to interfere with the complex biofilm communities that exist in non-healing wounds.</p></sec></body><back><fn-group><fn><p><bold>How to cite this article</bold>: Gullo A, Volti GL, Ristagno G. New burns and trauma journal celebrating translational research. Burn Trauma 2013;1:47&#x02013;50.</p><p><bold>Source of Support</bold>: Nil. <bold>Conflict of Interest</bold>: None declared.</p></fn></fn-group><ack><p>We gratefully acknowledge Jennifer Hurlow, GNP, CWOCN, Wound Practitioner, LLC, Memphis, TN, for the images and descriptions of the wounds in <xref rid="Fig1" ref-type="fig">Figures 1</xref>&#x02013;<xref rid="Fig3" ref-type="fig">3</xref>.</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Costerton</surname><given-names>JW</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Ghannoum</surname><given-names>M</given-names></name><name><surname>O&#x02019;Toole</surname><given-names>GA</given-names></name></person-group><article-title>A short history of the development of the biofilm concept</article-title><source>Microbial Biofilms</source><year>2004</year><publisher-loc>Washington, DC</publisher-loc><publisher-name>ASM Press</publisher-name><fpage>4</fpage><lpage>19</lpage></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geesey</surname><given-names>GG</given-names></name><name><surname>Richardson</surname><given-names>WT</given-names></name><name><surname>Yeomans</surname><given-names>HG</given-names></name><name><surname>Irvin</surname><given-names>RT</given-names></name><name><surname>Costerton</surname><given-names>JW</given-names></name></person-group><article-title>Microscopic examination of natural sessile bacterial populations from an alpine stream</article-title><source>Can J Microbiol</source><year>1977</year><volume>23</volume><fpage>1733</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1139/m77-249</pub-id><pub-id pub-id-type="pmid">340020</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costerton</surname><given-names>JW</given-names></name><name><surname>Geesey</surname><given-names>GG</given-names></name><name><surname>Cheng</surname><given-names>KJ</given-names></name></person-group><article-title>How bacteria stick</article-title><source>Sci Amer</source><year>1978</year><volume>238</volume><fpage>86</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1038/scientificamerican0178-86</pub-id><pub-id pub-id-type="pmid">635520</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reid</surname><given-names>G</given-names></name><name><surname>Chan</surname><given-names>RCY</given-names></name><name><surname>Bruce</surname><given-names>AW</given-names></name><name><surname>Costerton</surname><given-names>JW</given-names></name></person-group><article-title>Prevention of urinary tract infections in rats with an indigenous <italic>Lactobacillus casei</italic> strain</article-title><source>Infect Immunity</source><year>1985</year><volume>49</volume><fpage>320</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">3926645</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costerton</surname><given-names>JW</given-names></name><name><surname>Cheng</surname><given-names>KJ</given-names></name><name><surname>Geesey</surname><given-names>GG</given-names></name><name><surname>Ladd</surname><given-names>TI</given-names></name><name><surname>Nickel</surname><given-names>JC</given-names></name><name><surname>Dasgupta</surname><given-names>M</given-names></name><etal/></person-group><article-title>Bacterial biofilms in nature and disease</article-title><source>Ann Rev Microbiol</source><year>1987</year><volume>41</volume><fpage>435</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1146/annurev.mi.41.100187.002251</pub-id><pub-id pub-id-type="pmid">3318676</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nickel</surname><given-names>JC</given-names></name><name><surname>Ruseska</surname><given-names>I</given-names></name><name><surname>Wright</surname><given-names>JB</given-names></name><name><surname>Costerton</surname><given-names>JW</given-names></name></person-group><article-title>Tobramycin resistance of cells of <italic>Pseudomonas aeruginosa</italic> growing as biofilm on urinary catheter material</article-title><source>Antimicrob Agents Chemother</source><year>1985</year><volume>27</volume><fpage>619</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1128/AAC.27.4.619</pub-id><pub-id pub-id-type="pmid">3923925</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Percival</surname><given-names>SL</given-names></name><name><surname>Hill</surname><given-names>KE</given-names></name><name><surname>Malic</surname><given-names>S</given-names></name><name><surname>Thomas</surname><given-names>DW</given-names></name><name><surname>Williams</surname><given-names>DW</given-names></name></person-group><article-title>Antimicrobial tolerance and the significance of persister cells in recalcitrant chronic wound biofilms</article-title><source>Wound Rep Regen</source><year>2011</year><volume>19</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1111/j.1524-475X.2010.00651.x</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jesaitis</surname><given-names>AJ</given-names></name><name><surname>Franklin</surname><given-names>MJ</given-names></name><name><surname>Berglund</surname><given-names>D</given-names></name><name><surname>Sasaki</surname><given-names>M</given-names></name><name><surname>Lord</surname><given-names>CI</given-names></name><name><surname>Bleazard</surname><given-names>JB</given-names></name><etal/></person-group><article-title>Compromised host defense on <italic>Pseudomonas aeruginosa</italic> biofilms: Characterization of neutrophil and biofilm interactions</article-title><source>J Immunol</source><year>2003</year><volume>171</volume><fpage>4329</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.171.8.4329</pub-id><pub-id pub-id-type="pmid">14530358</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thurlow</surname><given-names>LR</given-names></name><name><surname>Hanke</surname><given-names>ML</given-names></name><name><surname>Fritz</surname><given-names>T</given-names></name><name><surname>Angle</surname><given-names>A</given-names></name><name><surname>Aldrich</surname><given-names>A</given-names></name><name><surname>Williams</surname><given-names>SH</given-names></name><etal/></person-group><article-title><italic>Staphylococcus aureus</italic> biofilms prevent macrophage phagocytosis and attenuate inflammation <italic>in vivo</italic></article-title><source>J Immunol</source><year>2011</year><volume>186</volume><fpage>6585</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1002794</pub-id><pub-id pub-id-type="pmid">21525381</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>James</surname><given-names>GA</given-names></name><name><surname>Swogger</surname><given-names>E</given-names></name><name><surname>Wolcott</surname><given-names>R</given-names></name><name><surname>Pulcini</surname><given-names>E</given-names></name><name><surname>Secor</surname><given-names>P</given-names></name><name><surname>Sestrich</surname><given-names>J</given-names></name><etal/></person-group><article-title>Biofilms in chronic wounds</article-title><source>Wound Repair Regen</source><year>2008</year><volume>16</volume><fpage>37</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1111/j.1524-475X.2007.00321.x</pub-id><pub-id pub-id-type="pmid">18086294</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirketerp-M&#x000f8;ller</surname><given-names>K</given-names></name><name><surname>Jenson</surname><given-names>PO</given-names></name><name><surname>Fazli</surname><given-names>M</given-names></name><name><surname>Madsen</surname><given-names>KG</given-names></name><name><surname>Pedersen</surname><given-names>J</given-names></name><name><surname>Moser</surname><given-names>C</given-names></name><etal/></person-group><article-title>Distribution, organization, and ecology of bacteria in chronic wounds</article-title><source>J Clin Microbiol</source><year>2008</year><volume>46</volume><fpage>2712</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1128/JCM.00501-08</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolcott</surname><given-names>RD</given-names></name><name><surname>Rhoads</surname><given-names>DD</given-names></name></person-group><article-title>A study of biofilm-based wound management in subjects with critical limb ischaemia</article-title><source>J Wound Care</source><year>2008</year><volume>17</volume><fpage>145</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.12968/jowc.2008.17.4.28835</pub-id><pub-id pub-id-type="pmid">18494432</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurlow</surname><given-names>J</given-names></name><name><surname>Bowler</surname><given-names>PG</given-names></name></person-group><article-title>Clinical experience with wound biofilm and management: A case series</article-title><source>Ostomy Wound Management</source><year>2009</year><volume>55</volume><fpage>38</fpage><lpage>49</lpage></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bjarnsholt</surname><given-names>T</given-names></name><name><surname>Kirketerp-M&#x000f8;ller</surname><given-names>K</given-names></name><name><surname>Jensen</surname><given-names>PO</given-names></name><name><surname>Madsen</surname><given-names>KG</given-names></name><name><surname>Phipps</surname><given-names>R</given-names></name><name><surname>Krogfelt</surname><given-names>K</given-names></name><etal/></person-group><article-title>Why chronic wounds will not heal: A novel hypothesis</article-title><source>Wound Repair Regen</source><year>2008</year><volume>16</volume><fpage>2</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1111/j.1524-475X.2007.00283.x</pub-id><pub-id pub-id-type="pmid">18211573</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fazli</surname><given-names>M</given-names></name><name><surname>Bjarnsholt</surname><given-names>T</given-names></name><name><surname>Kirketerp-M&#x000f8;ller</surname><given-names>K</given-names></name><name><surname>J&#x000f8;rgensen</surname><given-names>B</given-names></name><name><surname>Andersen</surname><given-names>AS</given-names></name><name><surname>Krogfelt</surname><given-names>KA</given-names></name><etal/></person-group><article-title>Nonrandom distribution of <italic>Pseudomonas aeruginosa</italic> and <italic>Staphylococcus aureus</italic> in chronic wounds</article-title><source>J Clin Microbiol</source><year>2009</year><volume>47</volume><fpage>4048</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1128/JCM.01395-09</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fazli</surname><given-names>M</given-names></name><name><surname>Bjarnsholt</surname><given-names>T</given-names></name><name><surname>Kirketerp-M&#x000f8;ller</surname><given-names>K</given-names></name><name><surname>J&#x000f8;rgensen</surname><given-names>A</given-names></name><name><surname>Andersen</surname><given-names>CB</given-names></name><name><surname>Givskov</surname><given-names>M</given-names></name><etal/></person-group><article-title>Quantitative analysis of the cellular inflammatory response against biofilm bacteria in chronic wounds</article-title><source>Wound Repair Regen</source><year>2011</year><volume>19</volume><fpage>387</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1111/j.1524-475X.2011.00681.x</pub-id><pub-id pub-id-type="pmid">21518086</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>A</given-names></name><name><surname>Zenilman</surname><given-names>JM</given-names></name><name><surname>Melendez</surname><given-names>JH</given-names></name><name><surname>Shirtliff</surname><given-names>ME</given-names></name><name><surname>Agostinho</surname><given-names>A</given-names></name><name><surname>James</surname><given-names>GA</given-names></name><etal/></person-group><article-title>The importance of a multifaceted approach to characterizing the microbial flora of chronic wounds</article-title><source>Wound Repair Regen</source><year>2011</year><volume>19</volume><fpage>532</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1111/j.1524-475X.2011.00720.x</pub-id><pub-id pub-id-type="pmid">22092791</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neut</surname><given-names>D</given-names></name><name><surname>Tijdens-Creusen</surname><given-names>EJ</given-names></name><name><surname>Bulstra</surname><given-names>SK</given-names></name><name><surname>van der Mei</surname><given-names>HC</given-names></name><name><surname>Busscher</surname><given-names>HJ</given-names></name></person-group><article-title>Biofilms in chronic diabetic foot ulcers &#x02014; a study of 2 cases</article-title><source>Acta Orthopaedica</source><year>2011</year><volume>82</volume><fpage>383</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.3109/17453674.2011.581265</pub-id><pub-id pub-id-type="pmid">21561305</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>P</given-names></name><name><surname>Brammah</surname><given-names>S</given-names></name><name><surname>Wills</surname><given-names>E</given-names></name></person-group><article-title>Burns, biofilm and a new appraisal of burn wound sepsis</article-title><source>Burns</source><year>2010</year><volume>36</volume><fpage>49</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/j.burns.2009.02.017</pub-id><pub-id pub-id-type="pmid">19523770</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Posnett</surname><given-names>J</given-names></name><name><surname>Franks</surname><given-names>PJ</given-names></name></person-group><article-title>The burden of chronic wounds in the UK</article-title><source>Nursing Times</source><year>2008</year><volume>104</volume><fpage>44</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">18293879</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Harding</surname><given-names>K</given-names></name><name><surname>Posnett</surname><given-names>J</given-names></name><name><surname>Vowden</surname><given-names>K</given-names></name></person-group><article-title>A new methodology for costing wound care</article-title><source>Int Wound J</source><year>2012</year></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurjala</surname><given-names>AN</given-names></name><name><surname>Geringer</surname><given-names>MR</given-names></name><name><surname>Seth</surname><given-names>AK</given-names></name><name><surname>Hong</surname><given-names>SJ</given-names></name><name><surname>Smeltzer</surname><given-names>MS</given-names></name><name><surname>Galiano</surname><given-names>RD</given-names></name><etal/></person-group><article-title>Development of a novel, highly quantitative <italic>in vivo</italic> model for the study of biofilm-impaired cutaneous wound healing</article-title><source>Wound Repair Regen</source><year>2011</year><volume>19</volume><fpage>400</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1111/j.1524-475X.2011.00690.x</pub-id><pub-id pub-id-type="pmid">21518094</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurlow</surname><given-names>J</given-names></name><name><surname>Bowler</surname><given-names>PG</given-names></name></person-group><article-title>Potential implications of biofilm in chronic wounds: A case series</article-title><source>J Wound Care</source><year>2012</year><volume>21</volume><fpage>109</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.12968/jowc.2012.21.3.109</pub-id><pub-id pub-id-type="pmid">22399078</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolcott</surname><given-names>R</given-names></name><name><surname>Cutting</surname><given-names>KF</given-names></name><name><surname>Dowd</surname><given-names>S</given-names></name></person-group><article-title>Surgical-site infections &#x02014; biofilms, dehiscence, and delayed healing</article-title><source>Wounds UK</source><year>2008</year><volume>4</volume><fpage>108</fpage><lpage>13</lpage></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolcott</surname><given-names>RD</given-names></name><name><surname>Rhoads</surname><given-names>DD</given-names></name><name><surname>Bennett</surname><given-names>ME</given-names></name><name><surname>Wolcott</surname><given-names>BM</given-names></name><name><surname>Gogokhia</surname><given-names>L</given-names></name><name><surname>Costerton</surname><given-names>JW</given-names></name><etal/></person-group><article-title>Chronic wounds and the medical biofilm paradigm</article-title><source>J Wound Care</source><year>2010</year><volume>19</volume><fpage>45</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.12968/jowc.2010.19.2.46966</pub-id><pub-id pub-id-type="pmid">20216488</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolcott</surname><given-names>R</given-names></name><name><surname>Dowd</surname><given-names>S</given-names></name></person-group><article-title>The role of biofilms: Are we hitting the right target?</article-title><source>Plast Reconstr Surg</source><year>2011</year><volume>127</volume><fpage>28s</fpage><lpage>35s</lpage><pub-id pub-id-type="doi">10.1097/PRS.0b013e3181fca244</pub-id><pub-id pub-id-type="pmid">21200270</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolcott</surname><given-names>RD</given-names></name><name><surname>Cox</surname><given-names>S</given-names></name></person-group><article-title>More effective cell-based therapy through biofilm suppression</article-title><source>J Wound Care</source><year>2013</year><volume>22</volume><fpage>26</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.12968/jowc.2013.22.1.26</pub-id><pub-id pub-id-type="pmid">23299355</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Branda</surname><given-names>SS</given-names></name><name><surname>Vik</surname><given-names>A</given-names></name><name><surname>Friedman</surname><given-names>L</given-names></name><name><surname>Kolter</surname><given-names>R</given-names></name></person-group><article-title>Biofilms: The matrix revisited</article-title><source>Trends Microbiol</source><year>2005</year><volume>13</volume><fpage>20</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2004.11.006</pub-id><pub-id pub-id-type="pmid">15639628</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cowan</surname><given-names>T</given-names></name></person-group><article-title>Visible biofilms &#x02014; a controversial issue!</article-title><source>J Wound Care</source><year>2012</year><volume>21</volume><fpage>106</fpage><pub-id pub-id-type="doi">10.12968/jowc.2012.21.3.106</pub-id><pub-id pub-id-type="pmid">22399077</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenselink</surname><given-names>E</given-names></name><name><surname>Andriessen</surname><given-names>A</given-names></name></person-group><article-title>A cohort study on the efficacy of a polyhexanide-containing biocellulose dressing in the treatment of biofilms in wounds</article-title><source>J Wound Care</source><year>2011</year><volume>20</volume><fpage>534</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.12968/jowc.2011.20.11.534</pub-id><pub-id pub-id-type="pmid">22240848</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>RJ</given-names></name><name><surname>Cutting</surname><given-names>KF</given-names></name></person-group><article-title>Wound biofilms &#x02014; are they visible?</article-title><source>J Wound Care</source><year>2012</year><volume>21</volume><fpage>140</fpage><lpage>1</lpage><pub-id pub-id-type="doi">10.12968/jowc.2012.21.3.140</pub-id><pub-id pub-id-type="pmid">22399082</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolcott</surname><given-names>RD</given-names></name><name><surname>Rumbaugh</surname><given-names>KP</given-names></name><name><surname>James</surname><given-names>G</given-names></name><name><surname>Schultz</surname><given-names>G</given-names></name><name><surname>Phillips</surname><given-names>P</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Biofilm maturity studies indicate sharp debridement opens a time-dependent therapeutic window</article-title><source>J Wound Care</source><year>2010</year><volume>19</volume><fpage>320</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.12968/jowc.2010.19.8.77709</pub-id><pub-id pub-id-type="pmid">20852503</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolcott</surname><given-names>RD</given-names></name><name><surname>Kennedy</surname><given-names>JP</given-names></name><name><surname>Dowd</surname><given-names>SE</given-names></name></person-group><article-title>Regular debridement is the main tool for maintaining a healthy wound bed in most chronic wounds</article-title><source>J Wound Care</source><year>2009</year><volume>18</volume><fpage>54</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.12968/jowc.2009.18.2.38743</pub-id><pub-id pub-id-type="pmid">19418781</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serralta</surname><given-names>VW</given-names></name><name><surname>Harrison-Balestra</surname><given-names>C</given-names></name><name><surname>Cazzaniga</surname><given-names>AL</given-names></name><etal/></person-group><article-title>Lifestyles of bacteria in wounds: presence of biofilms?</article-title><source>Wounds</source><year>2001</year><volume>13</volume><fpage>29</fpage><lpage>34</lpage></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>SC</given-names></name><name><surname>Ricotti</surname><given-names>C</given-names></name><name><surname>Cazzaniga</surname><given-names>A</given-names></name><name><surname>Welsh</surname><given-names>E</given-names></name><name><surname>Eaglstein</surname><given-names>WH</given-names></name><name><surname>Mertz</surname><given-names>PM</given-names></name></person-group><article-title>Microscopic and physiologic evidence for biofilm-associated wound colonization <italic>in vivo</italic></article-title><source>Wound Repair Regen</source><year>2008</year><volume>16</volume><fpage>23</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1111/j.1524-475X.2007.00303.x</pub-id><pub-id pub-id-type="pmid">18211576</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roche</surname><given-names>ED</given-names></name><name><surname>Renick</surname><given-names>PJ</given-names></name><name><surname>Tetens</surname><given-names>SP</given-names></name><name><surname>Ramsay</surname><given-names>SJ</given-names></name><name><surname>Daniels</surname><given-names>EQ</given-names></name><name><surname>Carson</surname><given-names>DL</given-names></name></person-group><article-title>Increasing the presence of biofilm and healing delay in a porcine model of MRSA-infected wounds</article-title><source>Wound Repair Regen</source><year>2012</year><volume>20</volume><fpage>537</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">22672311</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pastar</surname><given-names>I</given-names></name><name><surname>Nusbaum</surname><given-names>AG</given-names></name><name><surname>Gil</surname><given-names>J</given-names></name><name><surname>Patel</surname><given-names>SB</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Valdes</surname><given-names>J</given-names></name><etal/></person-group><article-title>Interactions of methicillin resistant <italic>Staphylococcus aureus</italic> USA300 and <italic>Pseudomonas aeruginosa</italic> in polymicrobial wound infection</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><fpage>e56846</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0056846</pub-id><pub-id pub-id-type="pmid">23451098</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rashid</surname><given-names>MH</given-names></name><name><surname>Rumbaugh</surname><given-names>K</given-names></name><name><surname>Passador</surname><given-names>L</given-names></name><name><surname>Davies</surname><given-names>DG</given-names></name><name><surname>Hamood</surname><given-names>AN</given-names></name><name><surname>Iglewski</surname><given-names>BH</given-names></name><etal/></person-group><article-title>Polyphosphate kinase is essential for biofilm development, quorum sensing, and virulence of <italic>Pseudomonas aeruginosa</italic></article-title><source>PNAS</source><year>2000</year><volume>97</volume><fpage>9636</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1073/pnas.170283397</pub-id><pub-id pub-id-type="pmid">10931957</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaber</surname><given-names>JA</given-names></name><name><surname>Triffo</surname><given-names>WJ</given-names></name><name><surname>Suh</surname><given-names>SJ</given-names></name><name><surname>Oliver</surname><given-names>JW</given-names></name><name><surname>Hastert</surname><given-names>MC</given-names></name><name><surname>Griswold</surname><given-names>JA</given-names></name><etal/></person-group><article-title><italic>Pseudomonas aeruginosa</italic> forms biofilms in acute infection independent of cell-to-cell signalling</article-title><source>Infect Immun</source><year>2007</year><volume>75</volume><fpage>3715</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1128/IAI.00586-07</pub-id><pub-id pub-id-type="pmid">17562773</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>G</given-names></name><name><surname>Hochwalt</surname><given-names>PC</given-names></name><name><surname>Usui</surname><given-names>ML</given-names></name><name><surname>Underwood</surname><given-names>RA</given-names></name><name><surname>Singh</surname><given-names>PK</given-names></name><name><surname>James</surname><given-names>GA</given-names></name><etal/></person-group><article-title>Delayed wound healing in diabetic (db/ db) mice with <italic>Pseudomonas aeruginosa</italic> biofilm challenge: A model for the study of chronic wounds</article-title><source>Wound Repair Regen</source><year>2010</year><volume>18</volume><fpage>467</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1111/j.1524-475X.2010.00608.x</pub-id><pub-id pub-id-type="pmid">20731798</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>G</given-names></name><name><surname>Usui</surname><given-names>ML</given-names></name><name><surname>Underwood</surname><given-names>RA</given-names></name><name><surname>Singh</surname><given-names>PK</given-names></name><name><surname>James</surname><given-names>GA</given-names></name><name><surname>Stewart</surname><given-names>PS</given-names></name><etal/></person-group><article-title>Time course study of delayed wound healing in a biofilm-challenged diabetic mouse model</article-title><source>Wound Repair Regen</source><year>2012</year><volume>20</volume><fpage>342</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1111/j.1524-475X.2012.00793.x</pub-id><pub-id pub-id-type="pmid">22564229</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watters</surname><given-names>C</given-names></name><name><surname>DeLeon</surname><given-names>K</given-names></name><name><surname>Trivedi</surname><given-names>U</given-names></name><name><surname>Griswold</surname><given-names>JA</given-names></name><name><surname>Lyte</surname><given-names>M</given-names></name><name><surname>Hampel</surname><given-names>KJ</given-names></name><etal/></person-group><article-title><italic>Pseudomonas aeruginosa</italic> biofilms perturb wound resolution and antibiotic tolerance in diabetic mice</article-title><source>Med Microbiol Immunol</source><year>2013</year><volume>202</volume><fpage>131</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1007/s00430-012-0277-7</pub-id><pub-id pub-id-type="pmid">23007678</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalton</surname><given-names>T</given-names></name><name><surname>Dowd</surname><given-names>SE</given-names></name><name><surname>Wolcott</surname><given-names>RD</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Watters</surname><given-names>C</given-names></name><name><surname>Griswold</surname><given-names>JA</given-names></name><etal/></person-group><article-title>An <italic>in vivo</italic> polymicrobial biofilm wound infection model to study interspecies interactions</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><fpage>e27317</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0027317</pub-id><pub-id pub-id-type="pmid">22076151</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schierle</surname><given-names>CF</given-names></name><name><surname>de la Garza</surname><given-names>M</given-names></name><name><surname>Mustoe</surname><given-names>TA</given-names></name><name><surname>Galiano</surname><given-names>RD</given-names></name></person-group><article-title>Staphylococcal biofilms impair wound healing by delaying reepithelialization in a murine cutaneous wound model</article-title><source>Wound Repair Regen</source><year>2009</year><volume>17</volume><fpage>354</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1111/j.1524-475X.2009.00489.x</pub-id><pub-id pub-id-type="pmid">19660043</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seth</surname><given-names>AK</given-names></name><name><surname>Geringer</surname><given-names>MR</given-names></name><name><surname>Gurjala</surname><given-names>AN</given-names></name><name><surname>Hong</surname><given-names>SJ</given-names></name><name><surname>Galiano</surname><given-names>RD</given-names></name><name><surname>Leung</surname><given-names>KP</given-names></name><etal/></person-group><article-title>Treatment of <italic>Pseudomonas aeruginosa</italic> biofilm-infected wounds with clinical wound care strategies: A quantitative study using an <italic>in vivo</italic> rabbit ear model</article-title><source>Plast Reconstr Surg</source><year>2012</year><volume>129</volume><fpage>262e</fpage><lpage>74e</lpage><pub-id pub-id-type="doi">10.1097/PRS.0b013e31823aeb3b</pub-id><pub-id pub-id-type="pmid">22286442</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seth</surname><given-names>AK</given-names></name><name><surname>Geringer</surname><given-names>MR</given-names></name><name><surname>Gurjala</surname><given-names>AN</given-names></name><name><surname>Abercrombie</surname><given-names>JA</given-names></name><name><surname>Chen</surname><given-names>P</given-names></name><name><surname>You</surname><given-names>T</given-names></name><etal/></person-group><article-title>Understanding the host inflammatory response to wound infection: An <italic>in vivo</italic> study of <italic>Klebsiella pneumoniae</italic> in a rabbit ear wound model</article-title><source>Wound Repair Regen</source><year>2012</year><volume>20</volume><fpage>214</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1111/j.1524-475X.2012.00764.x</pub-id><pub-id pub-id-type="pmid">22332606</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seth</surname><given-names>AK</given-names></name><name><surname>Geringer</surname><given-names>MR</given-names></name><name><surname>Galiano</surname><given-names>RD</given-names></name><name><surname>Leung</surname><given-names>KP</given-names></name><name><surname>Mustoe</surname><given-names>TA</given-names></name><name><surname>Hong</surname><given-names>SJ</given-names></name></person-group><article-title>Quantitative comparison and analysis of species-specific wound biofilm virulence using an <italic>in vivo</italic>, rabbit ear model</article-title><source>J Am Coll Surg</source><year>2012</year><volume>215</volume><fpage>388</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/j.jamcollsurg.2012.05.028</pub-id><pub-id pub-id-type="pmid">22704819</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seth</surname><given-names>AK</given-names></name><name><surname>Geringer</surname><given-names>MR</given-names></name><name><surname>Hong</surname><given-names>SJ</given-names></name><name><surname>Leung</surname><given-names>KP</given-names></name><name><surname>Galiano</surname><given-names>RD</given-names></name><name><surname>Mustoe</surname><given-names>TA</given-names></name></person-group><article-title>Comparative analysis of single-species and polybacterial wound biofilms using a quantitative, <italic>in vivo</italic>, rabbit ear model</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><fpage>e42897</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0042897</pub-id><pub-id pub-id-type="pmid">22905182</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>SC</given-names></name><name><surname>Martinez</surname><given-names>L</given-names></name><name><surname>Kirsner</surname><given-names>R</given-names></name></person-group><article-title>The diabetic foot: the importance of biofilms and wound bed preparation</article-title><source>Curr Diabetes Rep</source><year>2006</year><volume>6</volume><fpage>439</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1007/s11892-006-0076-x</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahn</surname><given-names>ST</given-names></name><name><surname>Mustoe</surname><given-names>TA</given-names></name></person-group><article-title>Effects of ischemia on ulcer wound healing: A new model in the rabbit ear</article-title><source>Ann Plast Surg</source><year>1990</year><volume>24</volume><fpage>17</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1097/00000637-199001000-00004</pub-id><pub-id pub-id-type="pmid">2301878</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seth</surname><given-names>AK</given-names></name><name><surname>Geringer</surname><given-names>MR</given-names></name><name><surname>Hong</surname><given-names>SJ</given-names></name><name><surname>Leung</surname><given-names>KP</given-names></name><name><surname>Mustoe</surname><given-names>TA</given-names></name><name><surname>Galiano</surname><given-names>RD</given-names></name></person-group><article-title><italic>In vivo</italic> modeling of biofilm-infected wounds: A review</article-title><source>J Surg Res</source><year>2012</year><volume>178</volume><fpage>330</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.jss.2012.06.048</pub-id><pub-id pub-id-type="pmid">22835953</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seth</surname><given-names>AK</given-names></name><name><surname>Geringer</surname><given-names>MR</given-names></name><name><surname>Nguyen</surname><given-names>KT</given-names></name><name><surname>Agnew</surname><given-names>SP</given-names></name><name><surname>Dumanian</surname><given-names>Z</given-names></name><name><surname>Galiano</surname><given-names>RD</given-names></name><etal/></person-group><article-title>Bacteriophage therapy for <italic>Staphylococcus aureus</italic> biofilm-infected wounds: A new approach to chronic wound care</article-title><source>Plast Reconstr Surg</source><year>2013</year><volume>131</volume><fpage>225</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1097/PRS.0b013e31827e47cd</pub-id><pub-id pub-id-type="pmid">23357984</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seth</surname><given-names>AK</given-names></name><name><surname>Nguyen</surname><given-names>KT</given-names></name><name><surname>Geringer</surname><given-names>MR</given-names></name><name><surname>Hong</surname><given-names>SJ</given-names></name><name><surname>Leung</surname><given-names>KP</given-names></name><name><surname>Mustoe</surname><given-names>TA</given-names></name><etal/></person-group><article-title>Noncontact, low-frequency ultrasound as an effective therapy against <italic>Pseudomonas aeruginosa</italic>-infected biofilm wounds</article-title><source>Wound Repair Regen</source><year>2013</year><volume>21</volume><fpage>266</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1111/wrr.12000</pub-id><pub-id pub-id-type="pmid">23421692</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leaper</surname><given-names>DJ</given-names></name><name><surname>Schultz</surname><given-names>G</given-names></name><name><surname>Carville</surname><given-names>K</given-names></name><name><surname>Fletcher</surname><given-names>J</given-names></name><name><surname>Swanson</surname><given-names>T</given-names></name><name><surname>Drake</surname><given-names>R</given-names></name></person-group><article-title>Extending the TIME concept: What have we learned in the past 10 years?</article-title><source>Int Wound J</source><year>2012</year><volume>9</volume><fpage>1</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1111/j.1742-481X.2012.01097.x</pub-id><pub-id pub-id-type="pmid">23145905</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strohal</surname><given-names>R</given-names></name><name><surname>Apelqvist</surname><given-names>J</given-names></name><name><surname>Dissemond</surname><given-names>J</given-names></name><etal/></person-group><article-title>EWMA document: debridement</article-title><source>J Wound Care</source><year>2013</year><volume>22</volume><fpage>S1</fpage><lpage>S52</lpage></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niezgoda</surname><given-names>JA</given-names></name><name><surname>Sordi</surname><given-names>PJ</given-names></name><name><surname>Hermans</surname><given-names>MH</given-names></name></person-group><article-title>Evaluation of Vashe Wound Therapy in the clinical management of patients with chronic wounds</article-title><source>Adv Skin Wound Care</source><year>2010</year><volume>23</volume><fpage>352</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1097/01.ASW.0000383198.35815.a2</pub-id><pub-id pub-id-type="pmid">20664326</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crew</surname><given-names>J</given-names></name><name><surname>Varilla</surname><given-names>R</given-names></name><name><surname>Rocas</surname><given-names>TA</given-names></name><name><surname>Debabov</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Najafi</surname><given-names>A</given-names></name><etal/></person-group><article-title>NeutroPhase&#x000ae; in chronic non-healing wounds</article-title><source>Int J Burns Trauma</source><year>2012</year><volume>2</volume><fpage>126</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">23272294</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Toole</surname><given-names>G</given-names></name><name><surname>Kaplan</surname><given-names>HB</given-names></name><name><surname>Kolter</surname><given-names>R</given-names></name></person-group><article-title>Biofilm as a microbial development</article-title><source>Ann Rev Microbiol</source><year>2000</year><volume>54</volume><fpage>49</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1146/annurev.micro.54.1.49</pub-id><pub-id pub-id-type="pmid">11018124</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marsh</surname><given-names>PD</given-names></name><name><surname>Bradshaw</surname><given-names>DJ</given-names></name></person-group><article-title>Dental plaque as a biofilm</article-title><source>J Industr Microbiol</source><year>1995</year><volume>15</volume><fpage>169</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1007/BF01569822</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall-Stoodley</surname><given-names>L</given-names></name><name><surname>Stoodley</surname><given-names>P</given-names></name><name><surname>Kathju</surname><given-names>S</given-names></name><name><surname>H&#x000f8;iby</surname><given-names>N</given-names></name><name><surname>Moser</surname><given-names>C</given-names></name><name><surname>Costerton</surname><given-names>JW</given-names></name><etal/></person-group><article-title>Towards diagnostic guidelines for biofilm-associated infections</article-title><source>FEMS Immunol Med Microbiol</source><year>2013</year><volume>65</volume><fpage>127</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1111/j.1574-695X.2012.00968.x</pub-id></element-citation></ref></ref-list></back></article>